Dr Reddy's recalls 50,000 bottles of Ondansetron tablets in USDr Reddy's Laboratories Inc is recalling 50,280 bottles of Ondansetron tablets 4 mg in a ongoing recall due to "failed impurities/degradati...
Pharma pricing authority NPPA puts cap on 18 formulations packs’ pricesFirms such as Cipla, Alembic Pharma and Unichem Laboratories will be impacted by the government's move for prices fixation and revision.
IPCA Labs plunges over 11% on USFDA alertIPCA Laboratories plunged over 11%in trade following reports that it has received US FDA import alert at two manufacturing facilities.
Ipca Labs hit by USFDA ban on plant for standard violations of production practicesThe FDA announced the ban, called import alert, in a notice on its website late on Thursday. It did not elaborate.
Aurobindo Pharmaceuticals gets USFDA nod for nausea injectionsThe injections are the generic equivalent of GlaxoSmithKline's Zofran injection, Aurobindo Pharma said.
- Aurobindo Pharma shares rise after USFDA nod for Ondansetron injections
Shares of Aurobindo Pharma moved higher in trade after the company got approval from the USFDA to manufacture and market Ondansetron inject...
- Lincoln Pharma gets patent approval for nasal spray treatment
Lincoln Pharmaceuticals on Monday said it has received patent approval for a nasal spray, which would help prevent vomiting and nausea.
- Pfizer recalls drug from US
PFIZER has recalled a drug made by an Indian partner from the US market while another local partner of the world’s largest drugmaker receiv...
- Claris recalls three anti-biotic drugs from US
Ahmedabad-based drug-maker Claris Lifesciences on Monday recalled three antibiotic drugs from the US market following an alert issued by th...
- Strides' Ondansetron gets Canada nod
Strides Arcolab has received approval from Canada's health department for selling Ondansetron injection.
- Strides gets nod for drug; share up 2.47%
Strides Arcolab Ltd has received ANDS approval for Ondansetron Injection 2 mg / ml.
- Glenmark gets nod to sell Zofran generic in US
Glenmark Pharmaceuticals has received final approval to market a generic version of GlaxoSmithKline’s popular anti-emetic drug Zofran, that...
- Glenmark gets USFDA nod to market cancer drugs
Glenmark Pharmaceuticals says it has received the US Food and Drug Administration approval to market two of its cancer drugs.
- Dr Reddy's gets a shot in the arm
Dr Reddy’s Laboratories’ performance in FY07 has got a boost from selling authorised generics and revenues from its various acquisitions.
- Dr Reddy’s logs Rs 325-crore net profit in Q4
Hyderabad-Based Dr Reddy’s has crossed revenues of $1.5 billion or Rs 6,500 crore in 2006-07 against Rs 2,400 crore (FY06) piggybacking on ...
- DRL gets US nod for multiple dosages of Ondansetron
Pharmaceutical firm Dr Reddy's Laboratories Ltd has received approval from the US Food and Drug Administration to market Ondansetron Hydroc...
- Sun Pharma gets nod for Ondansetron
Sun Pharmaceutical Industries Ltd has received tentative approval from the USFDA for the drug 'Ondansetron' in tablet form.